ロード中...
Overcoming Platinum Drug Resistance with Copper-lowering Agents
Platinum (Pt)-based antitumor agents have been the mainstay of cancer chemotherapy for the last three decades. While multiple mechanisms are responsible for treatment failure, deficiency in drug transport is an important contributor. The human high-affinity copper (Cu) transporter-1 (hCtr1) can also...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4001922/ https://ncbi.nlm.nih.gov/pubmed/24122978 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|